St Mark's Hospital, Harrow, UK.
Department of Surgery and Cancer, Imperial College, London, UK.
Colorectal Dis. 2019 Jan;21(1):73-78. doi: 10.1111/codi.14422. Epub 2018 Oct 8.
Restorative proctocolectomy has gained acceptance in the surgical management of medically refractive ulcerative colitis and cancer prevention in familial adenomatous polyposis. Incontinence following restorative proctocolectomy occurs in up to 25% of patients overnight. The Renew insert is an inert single-use device which acts as an anal plug. The aim of this study was to assess the acceptability, effectiveness and safety of the Renew insert in patients who have undergone restorative proctocolectomy. The device has yet to be assessed in patients who have undergone restorative proctocolectomy.
This was a prospective study exploring the acceptability, effectiveness and safety of the Renew insert in improving incontinence in patients who had undergone restorative proctocolectomy. A total of 15 patients with incontinence were asked to use the Renew insert for 14 days following their standard care. The Incontinence Questionnaire-Bowels was used pre- and posttreatment to assess response and patients were asked to report the perceived acceptability, effectiveness and safety of the device at the end of the trial.
The device was acceptable to 8/15 (53%) of patients and was effective in 6/15 (40%). Only 2/15 (13%) of patients raised any safety concerns, and these were minor. The device was associated with a significant reduction in night seepage (P = 0.034).
In a small study, the Renew insert can be both acceptable and effective and is also associated with few safety concerns. It is also associated with significant reductions in night-time seepage.
修复性直肠结肠切除术已被广泛应用于医学难治性溃疡性结肠炎的外科治疗以及家族性腺瘤性息肉病的癌症预防。修复性直肠结肠切除术后,多达 25%的患者会出现夜间失禁。Renew 植入物是一种惰性一次性使用装置,起到肛门塞的作用。本研究旨在评估该装置在接受修复性直肠结肠切除术的患者中的适用性、有效性和安全性。该装置尚未在接受修复性直肠结肠切除术的患者中进行评估。
这是一项前瞻性研究,旨在探索 Renew 植入物在改善接受修复性直肠结肠切除术的患者失禁方面的适用性、有效性和安全性。共 15 名失禁患者在接受标准护理后使用 Renew 植入物 14 天。在治疗前后使用粪便失禁问卷-肠道(Incontinence Questionnaire-Bowels)评估反应,患者在试验结束时报告对设备的可接受性、有效性和安全性的看法。
该装置被 8/15(53%)名患者接受,在 6/15(40%)名患者中有效。只有 2/15(13%)名患者提出了任何安全问题,且这些问题都很小。该装置与夜间渗漏显著减少相关(P=0.034)。
在一项小型研究中,Renew 植入物既具有良好的可接受性和有效性,也很少出现安全性问题。它还与夜间渗漏显著减少有关。